All In Biotech

Free tool

FAERS Monitor: Tiazac

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020401 or its brand name (Tiazac, Diltiazem Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

14,189

Serious

11,748

83% of reports

Hospitalization

6,405

Death reported

3,065

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,651
  • pain1,374
  • fatigue1,369
  • fall1,194
  • diarrhoea1,094
  • headache1,073
  • nausea1,070
  • arthralgia1,033
  • dizziness1,031
  • drug ineffective999
  • hypotension944
  • pruritus934
  • pyrexia911
  • off label use885
  • condition aggravated875

Reports by year received

View as table
YearReports
2004569
2005571
2006378
2007264
2008247
2009270
2010332
2011327
2012428
2013366
2014445
2015540
2016473
2017365
2018412
2019452
2020644
2021953
20221,478
20231,146
20241,383
20251,345
2026801

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,039,970 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypotensionSignal9447.06.64,876
fallSignal1,1945.35.14,252
dyspnoeaSignal1,6514.34.14,334
condition aggravatedSignal8754.34.02,218
pyrexiaSignal9113.93.71,998
arthralgiaSignal1,0333.73.52,058
pruritusSignal9343.63.41,787
painSignal1,3743.33.22,288
dizzinessSignal1,0313.12.91,467
fatigueSignal1,3692.62.51,407
headacheSignal1,0732.52.41,029
diarrhoeaSignal1,0942.52.41,027
nauseaSignal1,0702.01.9559
off label use8851.51.4153
drug ineffective9991.11.114

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.